STERLINBIO

Sterling Biotech Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2017

Sterling Biotech Limited has informed the Exchange that Annual General Meeting of members of the Company was held on June 30, 2009. The members present at the meeting have unanimously passed all the resolutions as per the notice of Annual General Meeting, briefly summarized as under: Ordinary Business and Ordinary Resolution: (1) Adoption of Annual Accounts for the year ended December 31, 2008. (2) Re-appointment of Shri V.D. Joshi as Director of the Company. (3) Re-appointment of Shri P.B. Mehta as Director of the Company (4) Appointment of H.S.Hathi & Co., as Auditors of the Company for the

Sterling Biotech Limited has informed the Exchange regarding the outcome of Annual General Meeting of the members of the company held on June 02, 2008.The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Sterling_Outcomeofagm_02062008.zip target=NEW> For more details click here.</a>

Sterling Biotech Limited has informed the Exchange that Extra Ordinary General Meeting of members of the company was held on March 05, 2008. The members of the company have unanimously passed the Special Resolutions for the following business: (1). Re-appointment of Shri Nitin J Sandesara as Managing Director of the Company for 5 years upto February 28, 2013.(2). Enabling resolution for Sponsored ADR, GDR. FCCB, etc to the extent of USD250 Million.(3). Enabling resolution for Issue of ADR, GDR, FCCB, etc. to the extent of USD250 Million.

Sterling Biotech Limited has informed the Exchange that the members of the Company in their 21st Annual General Meeting held on May 12, 2007 have transacted the following: (1) Declared a Dividend at the rate of 50% (Rs.0.50 per share of Rs.1/- each) for the year ended December 31, 2006. (2) Re-appointed Shri. R.B. Dixit as Director of the Company. (3) Re-appointed Shri. Vilas Joshi as Director of the Company. (4) Re-appointed M/s. H.S.Hathi & Co., Chartered Accountant as Auditors of the Company to hold office until the conclusion of next Annual General Meeting. (5) Passed Special Resolution fo

Sterling Biotech Limited has informed the Exchange that the AGM of the members of the company was held on June 26, 2006 to transact the business as set out in the notice sent to all the shareholders of the Company. The members present at the meeting have :- 1) Declare a dividend @50% (Rs.0.50 per equity share of Re.1/- each) for the year ended December 31, 2005. 2) Re-appointed Shri C. J. Sandesara as Director of the Company. 3) Re-appointed Shri P. B. Mehta as Director of the Company. 4) Re-appointed M/s H. S. Hathi & Co., Chartered Accountants as auditors of the Company to hold office until

Sterling Biotech Limited has informed the Exchange that shareholders at their EGM held on October 11, 2005, passed following enabling resolutions: 1) Authorizing Board u/s. 81(1)(A) of the Companies Act, 1956 for issue of Equity Shares / Warrants and / or any instrument convertible into Equity Shares, Global Depository Receipts (GDRs) / American Depository Receipts (ADRs) / FCCBs for an aggregate sum of US$ 50 million. 2) Authorizing Company / Board to borrow up to Rs.3000 crores as and when required, u/s. 293(1)(d) of the Companies Act, 1956 and 3) Authorizing Company / Board to charge the as

Sterling Biotech Limited has informed the Exchange that the AGM of the members of the company was held on June 27, 2005.The members present at the meeting have: 1) Approved and adopted the Audited Accounts of the company for the year ended December 31, 2004. 2) Declared a Dividend at the rate of 30% (Rs.0.30 per share of Rs.1/- each) for the year ended December 31, 2004. 3) Re-appointed Shri. N.B. Patel as Director of the Company. 4) Re-appointed Shri. R.B. Dixit as Director of the Company. 5) Re-appointed M/s. H.S. Hathi & Co., Chartered Accountants as Auditors of the Company to hold office u